Ulysses Management LLC Moderna, Inc. Transaction History

Ulysses Management LLC

  • $716 Million
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023
BUY
$118.5 - $160.53 $604,350 - $818,703
5,100 New
5,100 $619,000
Q4 2022

Feb 14, 2023
SELL
$118.38 - $210.04 $355,140 - $630,120
-3,000 Reduced 33.33%
6,000 $1.08 Million
Q3 2022

Nov 14, 2022
BUY
$118.07 - $194.18 $1.06 Million - $1.75 Million
9,000 New
9,000 $1.06 Million

Others Institutions Holding MRNA

# of Institutions
1,113
Shares Held
241M
Call Options Held
9.26M
Put Options Held
12.1M
View Full List

About Moderna, Inc.

MRNA Quotes by TradingView
  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Ulysses Management LLC Portfolio

Follow Ulysses Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ulysses Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ulysses Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email